Navigation Links
Challenges and promise of cell-based therapies
Date:4/1/2008

What: Challenges and Promise of Cell-Based Therapies is a one-day symposium to explore promising research in regenerative medicine using stem cells. The opening plenary session will feature an overview of hematopoietic stem cell therapy. This will be followed by four plenary sessions that will highlight cell-based therapies for the treatment of neurological, cardiac, musculoskeletal, and metabolic diseases and disorders. It will close with a presentation on induced pluripotent stem cells (iPSCs) and the issues that need to be addressed to enable their potential use in cell-based therapies.

Why: The purpose of the symposium is to determine productive new directions for research in regenerative medicine and to help NIH prioritize research with the greatest potential for clinical benefit.

Who: Speakers include:
Story C. Landis, Ph.D., National Institute of Neurological Disorders and Stroke, National Institutes of Health
James F. Battey, Jr., M.D., Ph.D., National Institute on Deafness and Other Communication Disorders, National Institutes of Health
Paolo Bianco, M.D., Sapienza Universita' di Roma
George Daley, M.D., Ph.D., Harvard Stem Cell Institute
Mark S. Freedman, M.D., M.Sc., University of Ottawa
Linda Griffith, Ph.D., Massachusetts Institute of Technology
Markus Grompe, M.D., Oregon Health & Science University
Douglas Kerr, M.D., Ph.D., Johns Hopkins University
Michael A. Laflamme, M.D., Ph.D., University of Washington
Annarosa Leri, M.D., Harvard Medical School
Douglas W. Losordo, M.D., Northwestern University
Stuart H. Orkin, M.D., Harvard Stem Cell Institute
Terence A. Partridge, Ph.D., Childrens National Medical Center
Darwin Prockop, M.D., Ph.D., Tulane University Medical School
Clive N. Svendsen, Ph.D., University of Wisconsin-Madison
Kenneth Zaret, Ph.D., Fox Chase Cancer Center

When: Tuesday, May 6, 2008, 8 a.m. to 5: 30 p.m.

Where: Natcher Conference Center, NIH Campus

Press Registration: For a registration form please send your name and email to nihsymposium@masimax.com, or call 866-710-0135 and leave your name and phone number. To be admitted into the symposium, you will need to show your press ID (or credentials) at the registration desk to receive a name badge.


'/>"/>

Contact: Marian Emr
301-496-5924
NIH/National Institute of Neurological Disorders and Stroke
Source:Eurekalert

Related biology news :

1. Challenges remain in reintroducing American chestnut
2. Choices and Challenges forum to address nuclear power issue
3. Triage study challenges notions of emergency medical response to disaster
4. Weird water: Discovery challenges long-held beliefs about waters special properties
5. Innovative civil engineering application promises cleaner waters
6. New CPR promises better results by compressing abdomen, not Chest
7. Tiny tubes and rods show promise as catalysts, sunscreen
8. New genetic research into nicotine addiction shows promise for personalized treatment
9. Genetic ancestral testing cannot deliver on its promise, study warns
10. Sweet potato shines as new promise for small enterprise and hunger relief in developing countries
11. Summer-dormant tall fescue grass shows promise for pasture improvements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... 2016 , ... In a new case report published today in STEM CELLS ... developed lymphedema after being treated for breast cancer benefitted from an injection of stem ... with this debilitating, frequent side effect of cancer treatment. , Lymphedema refers ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
Breaking Biology Technology: